BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14765379)

  • 1. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should radiotherapy be standard therapy for brain tumors in the elderly? Cons.
    Chinot OL
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):68-71. PubMed ID: 14765390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
    Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
    Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide.
    Kaloshi G; Sierra del Rio M; Ducray F; Psimaras D; Idbaih A; Laigle-Donadey F; Taillibert S; Houillier C; Dehais C; Omuro A; Sanson M; Delattre JY; Hoang-Xuan K
    J Neurooncol; 2010 Dec; 100(3):439-41. PubMed ID: 20464625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art treatment of high-grade brain tumors.
    Brandes AA
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):4-9. PubMed ID: 14765377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide for treating brain metastases.
    Abrey LE; Christodoulou C
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):34-42. PubMed ID: 11550137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of elderly patients with high-grade gliomas.
    Brandes AA; Monfardini S
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):58-62. PubMed ID: 14765388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy in the treatment of high grade gliomas.
    Lonardi S; Tosoni A; Brandes AA
    Cancer Treat Rev; 2005 Apr; 31(2):79-89. PubMed ID: 15847978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
    van den Bent MJ
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas.
    Corsa P; Parisi S; Raguso A; Troiano M; Perrone A; Cossa S; Munafò T; Piombino M; Spagnoletti G; Borgia F
    Tumori; 2006; 92(4):299-305. PubMed ID: 17036520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide for recurrent high-grade glioma.
    Macdonald DR
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):3-12. PubMed ID: 11550133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches for temozolomide therapy: use in newly diagnosed glioma.
    Stupp R; Newlands E
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuro-oncology: the growing role of chemotherapy in glioma.
    Carpentier AF
    Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
    [No Abstract]   [Full Text] [Related]  

  • 17. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Kyritsis AP; Levin VA
    Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of temozolomide in patients with progressive low-grade glioma.
    Quinn JA; Reardon DA; Friedman AH; Rich JN; Sampson JH; Provenzale JM; McLendon RE; Gururangan S; Bigner DD; Herndon JE; Avgeropoulos N; Finlay J; Tourt-Uhlig S; Affronti ML; Evans B; Stafford-Fox V; Zaknoen S; Friedman HS
    J Clin Oncol; 2003 Feb; 21(4):646-51. PubMed ID: 12586801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 20. Temozolomide: a milestone in neuro-oncology and beyond?
    Mutter N; Stupp R
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.